Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.6%

1 terminated/withdrawn out of 28 trials

Success Rate

96.4%

+9.9% vs industry average

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

7%

2 of 27 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 1
25(89.3%)
Phase 3
2(7.1%)
Phase 2
1(3.6%)
28Total
Phase 1(25)
Phase 3(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT00634049Phase 3Completed

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Role: collaborator

NCT00412893Phase 3Completed

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Role: collaborator

NCT03241550Phase 1Completed

A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Role: collaborator

NCT01407679Phase 2Terminated

Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

Role: collaborator

NCT01657838Phase 1Completed

Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects

Role: collaborator

NCT01582412Phase 1Completed

Drug Interaction Study of Isavuconazole and Digoxin

Role: collaborator

NCT01555866Phase 1Completed

Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.

Role: collaborator

NCT01657890Phase 1Completed

Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects

Role: collaborator

NCT01635972Phase 1Completed

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Role: collaborator

NCT01651325Phase 1Completed

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects

Role: collaborator

NCT01660477Phase 1Completed

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole

Role: collaborator

NCT01635946Phase 1Completed

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin

Role: collaborator

NCT02128893Phase 1Completed

A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole

Role: collaborator

NCT02128321Phase 1Completed

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine

Role: collaborator

NCT02059590Phase 1Completed

A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects

Role: collaborator

NCT01884636Phase 1Completed

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate

Role: collaborator

NCT01884558Phase 1Completed

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin

Role: collaborator

NCT01813461Phase 1Completed

Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects

Role: collaborator

NCT01809860Phase 1Completed

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects

Role: collaborator

NCT01555918Phase 1Completed

A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers

Role: collaborator